# ADAKVEO

NDC: 0078-0883
Generic name: crizanlizumab
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20191115

FDA application: BLA761128

## Active ingredients

- CRIZANLIZUMAB: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0883"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0883
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b2b7f8b4-fe9a-4a86-8129-9e43f99a20c6